ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.714,02
-0,28%
S&P 500
5.314,13
0,11%
Dow Jones
39.883,64
0,19%
Euro vs US Dollar
1,08607
0,00%
Bitcoin
70.331,75
-1,59%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Ayala Pharmaceuticals Inc (PK) (ADXS)

  7. Ayala Pharmaceuticals Inc (PK) (ADXS) News

ADXS

Ayala Pharmaceuticals (PK) (ADXS)

Ayala Pharmaceuticals Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ADXS
DatumZeitQuelleÜberschriftSymbolFirma
06/03/202413h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202414h16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/02/202422h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202423h22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202422h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202420h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202417h58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202414h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
09/02/202423h15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/02/202414h51Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202422h18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
21/11/202315h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
21/11/202315h00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202315h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202322h04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202322h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202316h46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202316h45Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202316h43Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202321h05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
31/10/202312h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
31/10/202312h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202312h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202312h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202312h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/10/202312h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/10/202322h31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202312h13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202312h10Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:ADXS

Kürzlich von Ihnen besucht

TG
960
AdvanSix
COIN
ETHBNTUSD
BNT Smart Token Relay
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten